I think market considering syngene as BIOSECURE(US rule) play… possibility of business shift from china to indian pharma players…and syngene is one of them…
3 Likes
I think market considering syngene as BIOSECURE(US rule) play… possibility of business shift from china to indian pharma players…and syngene is one of them…